RARE logo

RARE Selling, General & Administrative Expenses

Annual SGA

$321.61 M
+$11.81 M+3.81%

December 1, 2024

Summary

Performance

1-Year Change

+3.81%

3-Year Change

+46.2%

5-Year Change

+99.11%

15-Year Change

+221.9%

RARE SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.7%
RARE annual SGA is higher than 86.7% of companies in Healthcare sector

High & Low

All-time High

$321.61 M
RARE annual SGA is currently at an all-time high

3-Year Low

$219.98 M
RARE annual SGA is currently +46.20% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
RARE previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
RARE next annual earnings announcement has not yet been scheduled

OtherRAREexpensesmetrics:

Annual Total Expenses

$1.10 B
RARE annual total expenses is $1.10 billion

Annual Operating Expenses

$1.02 B
RARE annual total operating expenses is $1.02 billion

Annual Cost Of Goods Sold

$76.73 M
RARE annual cost of goods sold is $76.73 million

Annual Interest Expense

$63.04 M
RARE annual interest expense is $63.04 million

Quarterly SGA

$82.50 M
+$2.14 M+2.67%

December 1, 2024

Summary

Performance

3-Month Change

+2.67%

1-Year Change

+7.37%

3-Year Change

+38.81%

5-Year Change

+96.99%

RARE Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.82%
RARE quarterly SGA is higher than 85.82% of companies in Healthcare sector

High & Low

All-time High

$82.50 M
RARE quarterly SGA is currently at an all-time high

3-Year Low

$59.43 M
RARE quarterly SGA is currently +38.81% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
RARE previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 2, 2025
RARE next earnings announcement is scheduled for May 2, 2025

OtherRAREexpensesmetrics:

Quarterly Total Expenses

$287.15 M
RARE quarterly total expenses is $287.15 million

Quarterly Operating Expenses

$270.26 M
RARE quarterly total operating expenses is $270.26 million

Quarterly Cost Of Goods Sold

$16.89 M
RARE quarterly cost of goods sold is $16.89 million

Quarterly Interest Expense

$15.52 M
RARE quarterly interest expense is $15.52 million

TTM SGA

-$15.03 B
-$569.18 M-3.94%

December 1, 2024

Summary

Performance

3-Month Change

-4856.67%

1-Year Change

-4951.08%

3-Year Change

-6931.74%

5-Year Change

-9404.25%

RARE TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.59%
RARE TTM SGA is higher than 1.59% of companies in Healthcare sector

High & Low

All-time High

-$27.06 M

3-Year Low

-$15.03 B
RARE TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
RARE previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 2, 2025
RARE next earnings announcement is scheduled for May 2, 2025

OtherRAREexpensesmetrics:

Annual Total Expenses

$1.10 B
RARE annual total expenses is $1.10 billion

Annual Operating Expenses

$1.02 B
RARE annual total operating expenses is $1.02 billion

TTM Cost Of Goods Sold

$76.73 M
RARE TTM cost of goods sold is $76.73 million

TTM Interest Expense

$63.04 M
RARE TTM interest expense is $63.04 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$321.61 M
RARE annual SGA is $321.61 million

Annual Operating Expenses

$1.02 B
RARE annual total operating expenses is $1.02 billion

Annual Cost Of Goods Sold

$76.73 M
RARE annual cost of goods sold is $76.73 million

RARE Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.8%+7.4%-4951.1%
3 y3 years+46.2%+38.8%-6931.7%
5 y5 years+99.1%+97.0%-9404.3%

RARE Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+46.2%at high+38.8%-96.2%at low
5 y5-yearat high+99.1%at high+97.0%-193.2%at low
alltimeall timeat high>+9999.0%at high+9035.7%<-9999.0%at low

Ultragenyx Pharmaceutical Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$321.61 M(+3.8%)
$82.50 M(+2.7%)
$321.61 M(+1.8%)
Sep 2024
-
$80.35 M(-0.3%)
$315.95 M(+1.8%)
Jun 2024
-
$80.60 M(+3.1%)
$310.51 M(-0.3%)
Mar 2024
-
$78.16 M(+1.7%)
$311.31 M(+0.5%)
Dec 2023
$309.80 M(+11.4%)
$76.83 M(+2.6%)
$309.80 M(+1.3%)
Sep 2023
-
$74.92 M(-8.0%)
$305.81 M(+1.7%)
Jun 2023
-
$81.40 M(+6.2%)
$300.74 M(+4.6%)
Mar 2023
-
$76.65 M(+5.2%)
$287.47 M(+3.4%)
Dec 2022
$278.14 M(+26.4%)
$72.85 M(+4.3%)
$278.14 M(+5.1%)
Sep 2022
-
$69.84 M(+2.5%)
$264.72 M(+6.4%)
Jun 2022
-
$68.14 M(+1.2%)
$248.76 M(+6.3%)
Mar 2022
-
$67.31 M(+13.3%)
$234.04 M(+6.4%)
Dec 2021
$219.98 M(+20.3%)
$59.43 M(+10.3%)
$219.98 M(+4.0%)
Sep 2021
-
$53.88 M(+0.9%)
$211.59 M(+5.9%)
Jun 2021
-
$53.41 M(+0.3%)
$199.83 M(+5.9%)
Mar 2021
-
$53.26 M(+4.3%)
$188.68 M(+3.1%)
Dec 2020
$182.93 M(+13.3%)
$51.04 M(+21.2%)
$182.93 M(+5.3%)
Sep 2020
-
$42.12 M(-0.3%)
$173.77 M(+0.6%)
Jun 2020
-
$42.25 M(-11.1%)
$172.65 M(+1.4%)
Mar 2020
-
$47.52 M(+13.5%)
$170.21 M(+5.4%)
Dec 2019
$161.52 M(+26.5%)
$41.88 M(+2.1%)
$161.52 M(+4.8%)
Sep 2019
-
$41.01 M(+3.0%)
$154.12 M(+6.9%)
Jun 2019
-
$39.81 M(+2.5%)
$144.21 M(+6.7%)
Mar 2019
-
$38.83 M(+12.6%)
$135.12 M(+5.8%)
Dec 2018
$127.72 M
$34.48 M(+10.9%)
$127.72 M(-2.5%)
DateAnnualQuarterlyTTM
Sep 2018
-
$31.09 M(+1.2%)
$130.97 M(+6.2%)
Jun 2018
-
$30.72 M(-2.3%)
$123.37 M(+9.5%)
Mar 2018
-
$31.43 M(-16.7%)
$112.66 M(+12.8%)
Dec 2017
$99.91 M(+53.9%)
$37.72 M(+60.5%)
$99.91 M(+21.8%)
Sep 2017
-
$23.50 M(+17.5%)
$82.00 M(+8.3%)
Jun 2017
-
$20.00 M(+7.1%)
$75.68 M(+7.5%)
Mar 2017
-
$18.68 M(-5.7%)
$70.41 M(+8.4%)
Dec 2016
$64.94 M(+96.8%)
$19.81 M(+15.3%)
$64.94 M(+14.5%)
Sep 2016
-
$17.18 M(+16.6%)
$56.72 M(+14.0%)
Jun 2016
-
$14.74 M(+11.6%)
$49.77 M(+18.3%)
Mar 2016
-
$13.21 M(+13.9%)
$42.07 M(+27.5%)
Dec 2015
$33.00 M(+205.3%)
$11.59 M(+13.3%)
$33.00 M(+32.9%)
Sep 2015
-
$10.23 M(+45.4%)
$24.83 M(+41.2%)
Jun 2015
-
$7.04 M(+70.1%)
$17.58 M(+35.6%)
Mar 2015
-
$4.14 M(+20.9%)
$12.96 M(+19.9%)
Dec 2014
$10.81 M(+142.9%)
$3.42 M(+14.8%)
$10.81 M(+24.1%)
Sep 2014
-
$2.98 M(+23.1%)
$8.71 M(+29.5%)
Jun 2014
-
$2.42 M(+22.0%)
$6.73 M(+25.7%)
Mar 2014
-
$1.99 M(+50.3%)
$5.35 M(+20.3%)
Dec 2013
$4.45 M(+33.1%)
$1.32 M(+32.2%)
$4.45 M(+10.4%)
Sep 2013
-
$999.00 K(-4.7%)
$4.03 M(+32.9%)
Jun 2013
-
$1.05 M(-3.2%)
$3.03 M(+52.8%)
Mar 2013
-
$1.08 M(+19.9%)
$1.99 M(+119.9%)
Dec 2012
$3.34 M(+81.3%)
$903.00 K
$903.00 K
Dec 2011
$1.84 M
-
-

FAQ

  • What is Ultragenyx Pharmaceutical annual SGA?
  • What is the all time high annual SGA for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical annual SGA year-on-year change?
  • What is Ultragenyx Pharmaceutical quarterly SGA?
  • What is the all time high quarterly SGA for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical quarterly SGA year-on-year change?
  • What is Ultragenyx Pharmaceutical TTM SGA?
  • What is the all time high TTM SGA for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical TTM SGA year-on-year change?

What is Ultragenyx Pharmaceutical annual SGA?

The current annual SGA of RARE is $321.61 M

What is the all time high annual SGA for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high annual SGA is $321.61 M

What is Ultragenyx Pharmaceutical annual SGA year-on-year change?

Over the past year, RARE annual SGA has changed by +$11.81 M (+3.81%)

What is Ultragenyx Pharmaceutical quarterly SGA?

The current quarterly SGA of RARE is $82.50 M

What is the all time high quarterly SGA for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high quarterly SGA is $82.50 M

What is Ultragenyx Pharmaceutical quarterly SGA year-on-year change?

Over the past year, RARE quarterly SGA has changed by +$5.66 M (+7.37%)

What is Ultragenyx Pharmaceutical TTM SGA?

The current TTM SGA of RARE is -$15.03 B

What is the all time high TTM SGA for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high TTM SGA is -$27.06 M

What is Ultragenyx Pharmaceutical TTM SGA year-on-year change?

Over the past year, RARE TTM SGA has changed by -$15.34 B (-4951.08%)